MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Canadian Journal of Health Technologies
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

660 results · 1 filter active ·
Results by year
20212025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
660 works in the cohort · of 4,299,418page 13 of 14

Labels cover 1 of 660 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 660 of 660 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Zolbetuximab for Injection (Vyloy)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Dupilumab (Dupixent)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Avacopan (Tavneos)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Sotorasib (Lumakras)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Erdafitinib (Balversa)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Abemaciclib (Verzenio)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Infliximab (Remsima SC)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Eptinezumab (Vyepti)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Deucravacitinib (Sotyktu)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Capivasertib (Truqap)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Somatropin for Short Stature
Camille Santos, Jennifer Horton
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Luspatercept (Reblozyl)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ibrutinib
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Nivolumab (Opdivo)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Remdesivir (Veklury)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Azacitidine (Onureg)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Somapacitan (Sogroya)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Chemistry
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Caplacizumab (Cablivi)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ferric Carboxymaltose (Ferinject)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
fundaboutno affunlabeled
Avatrombopag (Doptelet)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Fecal Microbiota (Rebyota)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Eplontersen (Wainua)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Omaveloxolone (Skyclarys)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Dostarlimab (Jemperli)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Arts and Humanities
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Exagamglogene Autotemcel (Casgevy)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Naloxegol
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Amivantamab (Rybrevant)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Pharmacology, Toxicology and Pharmaceutics
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Inclisiran (Leqvio)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Prasterone (Intrarosa)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Materials Science
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Dostarlimab (Jemperli)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
fundaboutno affunlabeled
Tarlatamab (Imdelltra)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pertuzumab
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Belimumab (Benlysta)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Leuprolide Mesylate (Camcevi)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Caplacizumab (Cablivi)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Elranatamab (Elrexfio)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Point-of-Care Tests for Pancreatitis
Angela M. Barbara, Melissa Severn
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pitolisant Hydrochloride (Wakix)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Pharmacology, Toxicology and Pharmaceutics
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Edaravone Oral Suspension (Radicava)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Maribavir (Livtencity)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Deferiprone (Ferriprox)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Decision Sciences
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About